2623: Semaglutide Weight Loss Drugs Pros & Cons (Ozempic vs. Wegovy) (WW)
The Cabral Concept
Dr. Stephen Cabral
4.8 • 1.8K Ratings
🗓️ 12 April 2023
⏱️ 20 minutes
🧾️ Download transcript
Summary
I have said it before, but there is no magical pill…
There is a new class of pharmaceutical drugs that have been getting a lot of attention lately due to their ability to get results in terms of weight loss - but at what cost?
Today, I want to give you an unbiased look at how these drugs are being used, their actual effectiveness, and the risks associated with them…
So join me on today's #CabralConcept 2623 where I go over what semaglutide weight loss drugs (Ozempic vs. Wegovy) are and discuss the pros & cons - Enjoy the show and let me know what you thought!
- - -
For Everything Mentioned In Today's Show:
- - -
Get a FREE Copy of Dr. Cabral's Book:
- - -
Join the Community & Get Your Questions Answered:
- - -
Dr. Cabral's Most Popular At-Home Lab Tests:
> Complete Minerals & Metals Test
(Test for mineral imbalances & heavy metal toxicity)
- - -
> Complete Candida, Metabolic & Vitamins Test
(Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels)
- - -
> Complete Stress, Mood & Metabolism Test
(Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels)
- - -
> Complete Food Sensitivity Test
(Find out your hidden food sensitivities)
- - -
> Complete Omega-3 & Inflammation Test
(Discover your levels of inflammation related to your omega-6 to omega-3 levels)
- - -
Get Your Question Answered On An Upcoming HouseCall:
- - -
Would You Take 30 Seconds To Rate & Review The Cabral Concept?
The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to the Cabral Concept, where Bored Certified Naturopath and Integrative Health |
| 0:07.6 | Practitioner Dr. Stephen Cabral shares how he was diagnosed at the age of 17 with a life |
| 0:12.7 | altering illness and given no hope for recovery. |
| 0:15.6 | He was only after studying and traveling all over the world if he discovered how to combine |
| 0:19.9 | ancient Ayurvedic healing practices with state-of-the-art naturopathic and functional medicine |
| 0:24.9 | to fully rebalance the body and re-energize it with life. |
| 0:28.5 | It's time to discover how to get well, lose weight, and finally feel alive again. |
| 0:33.4 | And now here's your host, Dr. Stephen Cabral. |
| 0:42.7 | Welcome back to the show here on our wellness and weight loss Wednesday. |
| 0:47.4 | We're going to be exploring the topic. |
| 0:49.4 | You may have already started hearing about it about specific GLP1 drugs. |
| 0:54.6 | These are pharmaceuticals that are used typically in type 2 diabetes now being used for weight |
| 1:00.6 | loss. |
| 1:01.6 | And you'd be shocked at how many people are not qualifying for the drug, meaning they're |
| 1:06.6 | BMI or having type 2 diabetes yet they are still being prescribed to it by their doctor. |
| 1:12.2 | What I want to share with you are the actual results that people are getting from an unbiased |
| 1:16.2 | perspective, but also share with you some of the side effects that your doctor may never |
| 1:21.6 | share with you because they probably do not know they haven't looked into some of these |
| 1:25.7 | specific cases. |
| 1:26.7 | So let's dive right into it right now. |
| 1:29.0 | There is a class of drugs using something called semaglutide. |
| 1:34.0 | Now, people are just referring to this as they're taking semaglutide, but they're typically |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Dr. Stephen Cabral, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Dr. Stephen Cabral and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.